Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade-Reference-Cited by-同舟云学术

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

Published:2021-08-18 Issue:24 Volume:27 Page:6749-6760
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Terry Stéphane^ORCID,Dalban Cécile,Rioux-Leclercq Nathalie,Adam Julien,Meylan Maxime^ORCID,Buart Stéphanie,Bougoüin Antoine,Lespagnol Alexandra^ORCID,Dugay Frédéric,Moreno Irelka Colina,Lacroix Guillaume,Lorens James B.,Gausdal Gro,Fridman Wolf H.,Mami-Chouaib Fathia,Chaput Nathalie,Beuselinck Benoit,Chabaud Sylvie,Barros-Monteiro Janice,Vano Yann,Escudier Bernard,Sautès-Fridman Catherine^ORCID,Albiges Laurence,Chouaib Salem

Funder

NSERM, Université Paris-Saclay

Université de Paris

la Ligue Contre le Cancer

l'Institut National du Cancer and Direction générale de l'offre de soins

CARPEM program of the Sites Intégrés de Recherche sur le Cancer

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hallmarks of pancreatic cancer: spotlight on TAM receptors;eBioMedicine;2024-09

2. Personalized medicine: Clinical oncology on molecular view of treatment;World Journal of Clinical Oncology;2024-08-24

3. AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy;Frontiers in Immunology;2024-08-21

4. Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy;Acta Pharmaceutica Sinica B;2024-08

5. Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells;Cancer Science;2024-07-22